Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gene activation therapy: from the BLV model to HAM/TSP patients.
Lezin A, Olindo S, Belrose G, Signate A, Cesaire R, Smadja D, Macallan D, Asquith B, Bangham C, Bouzar A, Gillet N, Defoiche J, Florins A, Verlaeten O, Burny A, Willems L. Lezin A, et al. Among authors: bangham c. Front Biosci (Schol Ed). 2009 Jun 1;1(1):205-15. doi: 10.2741/S20. Front Biosci (Schol Ed). 2009. PMID: 19482696 Free article. Review.
Safety of long-term treatment of HAM/TSP patients with valproic acid.
Olindo S, Belrose G, Gillet N, Rodriguez S, Boxus M, Verlaeten O, Asquith B, Bangham C, Signaté A, Smadja D, Lezin A, Césaire R, Willems L. Olindo S, et al. Among authors: bangham c. Blood. 2011 Dec 8;118(24):6306-9. doi: 10.1182/blood-2011-04-349910. Epub 2011 Oct 13. Blood. 2011. PMID: 21998206 Free article. Clinical Trial.
The immune control of HTLV-1 infection: selection forces and dynamics.
Bangham CR, Meekings K, Toulza F, Nejmeddine M, Majorovits E, Asquith B, Taylor GP. Bangham CR, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14(8):2889-903. doi: 10.2741/3420. Front Biosci (Landmark Ed). 2009. PMID: 19273242 Free article. Review.
Cell dynamics and immune response to BLV infection: a unifying model.
Florins A, Gillet N, Asquith B, Boxus M, Burteau C, Twizere JC, Urbain P, Vandermeers F, Debacq C, Sanchez-Alcaraz MT, Schwartz-Cornil I, Kerkhofs P, Jean G, Théwis A, Hay J, Mortreux F, Wattel E, Reichert M, Burny A, Kettmann R, Bangham C, Willems L. Florins A, et al. Among authors: bangham c. Front Biosci. 2007 Jan 1;12:1520-31. doi: 10.2741/2165. Front Biosci. 2007. PMID: 17127399 Free article. Review.
Quantifying HTLV-I dynamics.
Asquith B, Bangham CR. Asquith B, et al. Immunol Cell Biol. 2007 Jun;85(4):280-6. doi: 10.1038/sj.icb.7100050. Epub 2007 Mar 20. Immunol Cell Biol. 2007. PMID: 17372609 Review.
The avidity and lytic efficiency of the CTL response to HTLV-1.
Kattan T, MacNamara A, Rowan AG, Nose H, Mosley AJ, Tanaka Y, Taylor GP, Asquith B, Bangham CR. Kattan T, et al. J Immunol. 2009 May 1;182(9):5723-9. doi: 10.4049/jimmunol.0900069. J Immunol. 2009. PMID: 19380819 Free article.
High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.
Goon PK, Igakura T, Hanon E, Mosley AJ, Asquith B, Gould KG, Taylor GP, Weber JN, Bangham CR. Goon PK, et al. Among authors: bangham cr. J Virol. 2003 Sep;77(17):9716-22. doi: 10.1128/jvi.77.17.9716-9722.2003. J Virol. 2003. PMID: 12915584 Free PMC article.
229 results